20 - Valent Pneumococcal Conjugate Vaccine (Prevenar 20)
Highlights:
- Includes seven additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) to strengthen the protection.
- Regardless of previous pneumococcal vaccination status, Prevenar 20 is well-tolerated and immunogenic.
- It is approved by the S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and currently is the conjugate pneumococcal vaccine that covers the most serotypes.
- This is a registered pharmaceutical product approved by the Pharmacy and Poisons Board of Hong Kong. It meets the criteria for safety, efficacy, and quality.
How:
- Intramuscular Injection
- Single-dose administration
Recommendation:
Suitable for individuals aged 18 or above
High-risk groups:
- Individuals aged 50 or above
- Individuals with chronic lung disease
- Individuals with cardiovascular disease
- Individuals with diabetes
- Individuals with weakened immune systems
- Smokers
Designated Quality HealthCare Medical Centres:
Click here for more details.
Scan & Book appointment via QHMS mobile app or WhatsApp 8301-8301

Recommended for
Suitable for individuals aged 18 or above